Clinical Trial Update: Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay

View source ↗

Summary

The document reports completion of a clinical trial evaluating the performance of Micromedic's CD24 in Vitro Diagnostic Assay for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Micromedic CD24 in Vitro Diagnostic Assay (CD24 in vitro diagnostic assay)

Snippet

Sponsor: Meir Medical Center | Conditions: Colorectal Cancer | Status: COMPLETED